Compounded glutathione injectables recalled nationwide after a supplement grade ingredient sent patients to hospital

On August 27, 2026 FDA said it was aware of at least 30 patients with adverse events after intravenous glutathione, alone or in blends, compounded by different pharmacies that all bought glutathione lot 229536 from Medisca Inc. The material was labelled dietary supplement grade, which FDA says is not an appropriate ingredient for an injectable. Reported effects included fever, chills, signs of shock and sepsis like symptoms, with hospitalizations, consistent with endotoxin exposure. Two Texas pharmacies had already recalled.

On September 9, 2026 Centric Compounding of Houston announced a consumer level recall of six lots of Glutathione 200 mg per mL, Myer's Cocktail and Tri-Immune Boost 30 mL multidose vials, which FDA posted on September 13. The firm reported nine adverse event reports and said the products had been distributed nationwide to patients by home delivery and to prescribers. FDA's alert tells compounders to know their ingredient suppliers and never use supplement grade material in injectables.

• 503A compounders making IV nutrient, glutathione or other wellness injectables.
• Telehealth, med spa and wellness programs that prescribe or administer them, and the pharmacies shipping vials to patients' homes.

Reaches any compounder making injectable products, and in particular the wellness injectable market: IV nutrient blends, glutathione and similar products shipped to patients or clinics.

1. Check every injectable's ingredient sourcing against the supplier's certificate of analysis and grade statement; remove anything labelled for dietary supplement or research use.
2. If you bought glutathione from Medisca in 2026, confirm the lot number and follow the supplier's and FDA's instructions to your customers.
3. Review your recall procedure for home delivered products, including how you reach patients directly and how refunds are handled.

Compounding (503A and 503B). The Compounding domain covers the substances a pharmacy compounds and where they come from. Ingredient grade and supplier qualification for injectables sit inside that review.

• Centric Compounding Issues Nationwide Recall of Glutathione, Myer's Cocktail, and Tri-Immune Boost Due to Elevated Endotoxin Levels
  PrimaryU.S. Food and Drug Administration (company announcement posted by FDA)Retrieved Sep 22, 2026

  Release dated 9/9/2026; six lots; nine adverse event reports; nationwide distribution to patients by home delivery and to prescribers; FDA posting date 09/13/2026.

• FDA reminds compounders not to use dietary supplement grade glutathione for injectables
  PrimaryU.S. Food and Drug AdministrationRetrieved Sep 22, 2026

  Alert dated 8/27/2026: at least 30 patients; Medisca lot 229536 labelled dietary supplement grade; two Texas recalls; Medisca's August 20 notice to customers.